Not meant to dissuade against COVID vax, but to sensitize clinicians to this rare, but potentially fatal disease in post-vax era. MDA5-Dermatomyositis from COVID-19 vaccine
https://t.co/Ab8yrGOnQb
2024 Rheumatology Year in Review
2024 was a year of surprising new growth in technology, with the expansion of new therapeutic options for many patients and clinicians.
https://t.co/JjG8oYTkKQ
💫 Check out the new #RheumMadness x @ RheumOnePagers Bracket Infographic 🏀📟
📚 Read the most innovative #rheum articles (last 2 yrs)
🎧 Check out the Rheum Madness Podcasts
🗳️ Submit your Brackets before April 1, 2025
Collaboration with Rheum Madness Team x @DavidLeverenz
Founder friend is building "Topgolf for Tennis"
Looks promising:
• Space is hot - BlackRock invested $150M into Puttshack; Calloway w/ $3B in Topgolf
• Space has grown 400% since '01
• Founding team is brilliant
Space left in the round for angels who love tennis. DM me.
Important to consider MIS-A in the differential diagnosis when evaluating patients with systemic symptoms after a recent SARS-CoV-2 infection despite treatment with monoclonal antibody infusions🦠
https://t.co/wQftwKDd1D
@RheumDanielG@UTMBInternalMed@miaowlex